Find uplifting stories about heroes, innovations, and solutions
37 results for "novo nordisk"
Pharmaceutical giant Novo Nordisk is teaming up with OpenAI to use artificial intelligence to discover new treatments faster and get them to patients sooner. The partnership could accelerate breakthroughs for millions living with obesity and diabetes.
OpenAI is partnering with pharmaceutical giant Novo Nordisk to use AI for discovering new medicines faster. The collaboration aims to supercharge scientists, not replace them, while tackling everything from drug discovery to supply chain efficiency.
Popular weight-loss and diabetes medications are getting dramatically more affordable. Novo Nordisk announced it will slash prices by up to half, potentially bringing monthly costs down to just $25 for many patients.
Novo Nordisk's pill version of the blockbuster weight loss drug Wegovy is launching with impressive momentum. The oral alternative to injections could make life-changing treatment easier for millions.
Two pharmaceutical giants just released the first truly effective weight loss pills after years of failed attempts. The new medications could make obesity treatment as easy as taking a daily tablet.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
France just became the first EU country to cover breakthrough obesity medications for severely obese patients, helping one million people access treatments that previously cost €300 per month. The bold public health move recognizes obesity as a serious medical condition deserving national support.
A daily pill helped patients lose 16% of their body weight in 44 weeks, outperforming other oral medications in development. The breakthrough could make obesity treatment more accessible to millions who avoid injections.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
Sixteen major pharmaceutical companies agreed to cut prescription drug prices for Americans through a new discount platform called TrumpRx. Popular medications including weight-loss drugs, diabetes treatments, and asthma inhalers will now cost significantly less for millions of consumers.
Starting this weekend, affordable generic versions of Ozempic and Wegovy will reach countries representing 40% of the world's population. Prices could eventually drop to $15 per month, making the life-changing medication accessible to millions who couldn't afford it before.
Eli Lilly is building a $3.5 billion manufacturing facility in Pennsylvania to produce breakthrough obesity treatments, including an experimental drug showing record-breaking weight loss results. The plant will create 850 permanent jobs and 2,000 construction positions when it opens in 2031.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A new, more powerful version of Wegovy just got FDA approval and could help people who haven't reached their weight loss goals with standard doses. The higher-dose shot helped study participants lose an extra 8 pounds on average.
More than 10 million Americans just regained insurance coverage for a life-changing obesity treatment after CVS reversed its restrictions on Zepbound. The win came after drugmaker Eli Lilly slashed prices to make the medication more accessible.
Millions seeking weight loss solutions can now access a daily pill instead of weekly injections. The FDA approved Eli Lilly's Foundayo, making treatment easier and more accessible for people nationwide.
%2Ffile%2Fattachments%2F2992%2F13971407_975900.jpg)
Starting mid-June, France becomes the first EU nation to reimburse life-changing weight-loss medications for severely obese patients. Up to one million people could access treatments that currently cost €300 monthly out of pocket.
A new AI tool named after DNA pioneer Rosalind Franklin is helping scientists discover life-saving drugs faster than ever before. Major pharmaceutical companies including Moderna and Amgen are already seeing results.
OpenAI just launched GPT-Rosalind, an AI model designed to speed up the painfully slow process of bringing new medicines to patients. Major pharma companies like Moderna and Amgen are already putting it to work.
Consumer advocates are asking the government to authorize cheaper versions of popular weight loss and diabetes medications that millions of Americans can't afford. The move could help patients nationwide access drugs that have been out of reach due to high prices.
Showing 20 of 37